Shannon Soqui

Ackrell Capital LLC operates as an independent investment bank that focuses on providing financial advisory services. It offers M&A advisory, private placement and corporate development services. The company was founded by Michael Kevin Ackrell and William A. Lamkin in 2003 and is headquartered in San Francisco, CA.

CMLM Holdings, Inc. provides hemp-formulated wellness and beauty products. The company is headquartered in Portland, OR.

Hempyre Holdings Ltd. engages in the distribution of hemp-formulated consumer packaged goods for beauty, beverage, and wellness industries. The firm focuses on consumer hemp-formulated topical solutions to protect and rejuvenate the skin and body. Its product brands include QIND, Bio-Synergy, Muhu, QINDNESS, ActiVeman, Active Woman, Super7, Bottomley Distillers, Green Origin, Paways, and Wevapers. The company was founded on February 13, 2020 and is headquartered in London, the United Kingdom.

Ackrell SPAC Partners I Co. is a blank check company. It plans to identify and to complete initial business combination in alcoholic and non-alcoholic beverage and wellness sectors of the fast-moving consumer goods market. The company was founded on September 11, 2018 and is headquartered in Claymont, DE.

Next Frontier Brands engages in the provision of consumer goods. It offers beverage and hemp-based wellness brands. The company is headquartered in Boulder, CO.

Next Frontier Pharmaceuticals, Inc. is a drug developer and provider of cannabinoid and psychedelic APIs. The private company is based in Carrollton, TX. Its wholly owned subsidiary, Benuvia Manufacturing, Inc., owns the FDA-approved cannabinoid drug Syndros® and the largest captive synthetic cannabinoid manufacturing facility. The company's 83,000 square foot manufacturing facility is permitted by the U.S. DEA to manufacture and export Schedule I to III controlled substances and is FDA registered. Next Frontier Pharmaceuticals is pursuing a 505(b)(2) approval pathway with the FDA for six investigational new drugs (INDs). The company also has a robust portfolio of patents and patents pending on organic and synthetic cannabinoids and provides life cycle management services for drug development companies focused on cannabinoids and psychedelics.